Embryonic Stem Cells in Clinical Trials: Current Overview of Developments and Challenges

Area of Science:

• Developmental Biology
• Regenerative Medicine
• Stem Cell Research

Background:

• Human embryonic stem cells (hESC) offer significant potential for developmental biology and regenerative medicine.
• hESC differentiation into precursor cells shows promise for treating incurable diseases.
• The field is constrained by notable ethical and experimental limitations.

Purpose of the Study:

• To review clinical trial studies involving hESC.
• To analyze the advantages, limitations, and concerns associated with hESC.
• To discuss ongoing research and future directions for hESC-based therapies.

Main Methods:

• Literature review of clinical trial studies on hESC.
• Analysis of current advancements and challenges in hESC applications.
• Examination of ethical and experimental considerations.

Main Results:

• Several hESC limitations have been addressed, with ongoing clinical trials.
• hESC applications are being improved, especially for macular and neurodegenerative diseases.
• Significant issues require further research and discussion for hESC-based therapy.

Conclusions:

• hESC-based therapy is not yet in conventional clinical application due to limitations.
• More data and research are essential to overcome clinical and ethical barriers.
• Resolving hESC limitations could position them as superior to other stem cell sources.